Assembly Biosciences reported earnings of -$ 0.93 per ASMB share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.66 |
| Earnings Per Share (Surprise) | -$ 0.93 (-$ 0.28) |
| Last Year's EPS | -$ 0.18 |
| EPS YoY Change |
Out of the last 70 earnings reporting periods, Assembly Biosciences beat analysts’ expectations 26 times and fell short of expectations 27 time(s). Assembly Biosciences reported earnings per share of -$ 0.93 in the last report falling to reach an estimated EPS of -$ 0.66 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.66 | -$ 0.93 | -$ 0.72 | |
| Aug 13, 2026 | -$ 0.72 | -$ 0.20 | -$ 1.33 | |
| May 7, 2026 | -$ 0.73 | -$ 0.54 | -$ 1.17 | |
| Mar 19, 2026 | -$ 0.51 | $ 2.48 | -$ 1.57 | |
| Nov 10, 2025 | -$ 0.50 | -$ 0.72 | -$ 1.51 | |
| Aug 6, 2025 | -$ 0.65 | -$ 1.33 | -$ 1.98 | |
| May 8, 2025 | -$ 2.01 | -$ 1.17 | -$ 1.66 | |
| Mar 20, 2025 | -$ 1.75 | -$ 1.57 | -$ 2.15 | |
| Nov 7, 2024 | -$ 2.02 | -$ 1.51 | -$ 3.24 | |
| Aug 8, 2024 | -$ 2.96 | -$ 1.98 | -$ 3.84 | |
| May 8, 2024 | -$ 2.74 | -$ 1.66 | -$ 4.44 | |
| Mar 27, 2024 | -$ 2.88 | -$ 2.15 | -$ 5.52 | |
| Nov 8, 2023 | -$ 2.76 | -$ 3.24 | -$ 5.76 | |
| Aug 9, 2023 | -$ 3.48 | -$ 3.84 | -$ 6.12 | |
| May 4, 2023 | -$ 4.44 | -$ 4.44 | -$ 5.76 | |
| Mar 22, 2023 | -$ 6.72 | -$ 5.52 | -$ 4.92 | |
| Nov 8, 2022 | -$ 5.64 | -$ 5.76 | -$ 4.92 | |
| Aug 9, 2022 | -$ 5.88 | -$ 6.12 | -$ 6.60 | |
| May 12, 2022 | -$ 5.88 | -$ 5.76 | -$ 8.28 | |
| Mar 10, 2022 | -$ 5.83 | -$ 4.92 | -$ 13.33 |
Assembly Biosciences’s stock was trading at $ 22.37 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, ASMB’s price decreased to $ 21.12 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.93 | $ 22.37 | $ 21.12 | |
| Aug 13, 2026 | -$ 0.20 | $ 27.06 | $ 32.95 | |
| May 7, 2026 | -$ 0.54 | $ 31.36 | $ 29.74 | |
| Mar 19, 2026 | $ 2.48 | $ 27.52 | $ 28.46 | |
| Nov 10, 2025 | -$ 0.72 | $ 31.20 | $ 33.13 | |
| Aug 6, 2025 | -$ 1.33 | $ 18.86 | $ 21.22 | |
| May 8, 2025 | -$ 1.17 | $ 12.41 | $ 12.24 | |
| Mar 20, 2025 | -$ 1.57 | $ 10.85 | $ 11.01 | |
| Nov 7, 2024 | -$ 1.51 | $ 16.65 | $ 16.78 | |
| Aug 8, 2024 | -$ 1.98 | $ 12.62 | $ 13.00 | |
| May 8, 2024 | -$ 1.66 | $ 12.62 | $ 13.01 | |
| Mar 27, 2024 | -$ 2.15 | $ 13.06 | $ 13.30 | |
| Nov 8, 2023 | -$ 3.24 | $ 10.68 | $ 9.00 | |
| Aug 9, 2023 | -$ 3.84 | $ 12.96 | $ 12.84 | |
| May 4, 2023 | -$ 4.44 | $ 12.00 | $ 12.36 | |
| Mar 22, 2023 | -$ 5.52 | $ 14.40 | $ 12.84 | |
| Nov 8, 2022 | -$ 5.76 | $ 17.76 | $ 15.72 | |
| Aug 9, 2022 | -$ 6.12 | $ 25.56 | $ 26.04 | |
| May 12, 2022 | -$ 5.76 | $ 16.20 | $ 18.48 | |
| Mar 10, 2022 | -$ 4.92 | $ 18.84 | $ 18.12 |
Assembly Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Assembly Biosciences missed analysts’ expectations during the last earnings period by
